A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients. [electronic resource]
Producer: 20141013Description: 290-9 p. digitalISSN:- 2567-689X
- Acute Coronary Syndrome -- blood
- Blood Platelets -- drug effects
- Cost-Benefit Analysis
- Decision Support Techniques
- Decision Trees
- Drug Costs
- Humans
- Models, Economic
- Patient Selection
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Function Tests -- economics
- Precision Medicine -- economics
- Predictive Value of Tests
- Purinergic P2Y Receptor Antagonists -- adverse effects
- Receptors, Purinergic P2Y12 -- blood
- Risk Assessment
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.